Johnson & Johnson

JNJ NYS
Pharmaceuticals
New Brunswick, NJ
2016 Revenue (US$ Millions)$71,890
Revenue Growth (%)2.59%
2015 Revenue (US$ Millions)$70,074
Net Income (US$ Millions)$16,540
Common Shares Outstanding (Millions)2,706.51
Earnings Per Share (US$)$5.93
Price to Earnings Ratio20.76
Total Equity (US$ Millions)$70,418
Return on Equity (%)23.25%
Long Term Debt (US$ Millions)$22,442
Debt to Equity Ratio (%)0.32%
Market Capitalization (US$ Millions)$311,817
Total Assets (US$ Millions)$141,208
Current Assets (US$ Millions)$65,032
Inventories (US$ Millions)$8,144
Current Liabilities (US$ Millions)$26,287
Cost Of Goods Sold (US$ Millions)$21,685
Asset Turnover0.52
Inventory Turnover2.68